GSK Q1 Core Profit Rises; Affirms 2026 Guidance

GSK reported first-quarter pretax profit of 2.14 billion pounds, up slightly from 2.11 billion pounds a year earlier, while EPS rose to 42.6 pence from 39.3 pence. Core operating profit increased 5% year over year on an AER basis and 10% CER, indicating solid underlying performance. The release is modestly positive, though no guidance change or major catalyst was provided in the excerpt.

Analysis

GSK reported first-quarter pretax profit of 2.14 billion pounds, up slightly from 2.11 billion pounds a year earlier, while EPS rose to 42.6 pence from 39.3 pence. Core operating profit increased 5% year over year on an AER basis and 10% CER, indicating solid underlying performance. The release is modestly positive, though no guidance change or major catalyst was provided in the excerpt.